Announcement on Resolutions of the 19th Meeting of the 6th Board of Directors
Securities code: 603392 Securities abbreviation: Wantai Biotechnology Announcement number: 2026-041
Beijing Wantai Biopharmaceutical Co., Ltd.
Announcement of Resolutions of the 19th Meeting of the Sixth Board of Directors
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
1. Convening of board of directors meetings
Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") sent the notice and meeting materials for the 19th meeting of the sixth board of directors to all directors by email on August 7, 2026. This meeting will be held by communication on August 19, 2026. This meeting was presided over by Mr. Qiu Zixin, the chairman of the company. 8 directors were supposed to be present, but 8 directors were actually present. The number of attendees, convening and voting methods of this meeting comply with the relevant provisions of the Company Law, other laws and regulations, and the Articles of Association, and are legal and valid.
2. Review status of board of directors meeting
- Reviewed and approved the "Full Text and Summary of the 2026 Semi-annual Report"
For details, please refer to the full text and summary of the company's 2026 semi-annual report disclosed by the company in designated information disclosure media.
Voting results: 8 votes in favor, 0 votes against, and 0 abstentions.
The proposal has been reviewed and approved by the Audit Committee of the sixth session of the Board of Directors.
- Considered and approved the "Proposal on the Special Report on the Deposit, Management and Actual Use of Funds Raised by the Company in the Half-Year of 2026"
For details, please refer to the "Special Report of Beijing Wantai Biopharmaceutical Co., Ltd. on the Storage, Management and Actual Use of Funds Raised in the Half-Year of 2026" disclosed by the company in the designated information disclosure media (Announcement Number: 2026-042).
Voting results: 8 votes in favor, 0 votes against, and 0 abstentions.
Announcement is hereby made.
Board of Directors of Beijing Wantai Biopharmaceutical Co., Ltd.
August 20, 2026